These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7749951)

  • 1. Development of ASHP therapeutic guidelines.
    Dotson LR; Witmer DR
    Am J Health Syst Pharm; 1995 Feb; 52(3):254-5. PubMed ID: 7749951
    [No Abstract]   [Full Text] [Related]  

  • 2. ASHP guidelines for the use of investigational drugs in institutions.
    Am J Hosp Pharm; 1983 Mar; 40(3):449-51. PubMed ID: 6846357
    [No Abstract]   [Full Text] [Related]  

  • 3. ASHP professional policy recommendations--Invitation to comment.
    Am J Health Syst Pharm; 2010 Apr; 67(8):e5-10. PubMed ID: 20360574
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP guidelines on documenting pharmaceutical care in patient medical records.
    American Society of Hospital Pharmacists
    Am J Health Syst Pharm; 2003 Apr; 60(7):705-7. PubMed ID: 12701556
    [No Abstract]   [Full Text] [Related]  

  • 5. ASHP guidelines for the use of investigational drugs in institutions.
    Am J Hosp Pharm; 1979 Feb; 36(2):221-2. PubMed ID: 420212
    [No Abstract]   [Full Text] [Related]  

  • 6. ASHP guidelines on preventing medication errors with chemotherapy and biotherapy.
    Goldspiel B; Hoffman JM; Griffith NL; Goodin S; DeChristoforo R; Montello CM; Chase JL; Bartel S; Patel JT
    Am J Health Syst Pharm; 2015 Apr; 72(8):e6-e35. PubMed ID: 25825193
    [No Abstract]   [Full Text] [Related]  

  • 7. ASHP statement on the use of medications for unlabeled uses.
    Am J Hosp Pharm; 1992 Aug; 49(8):2006-8. PubMed ID: 1442846
    [No Abstract]   [Full Text] [Related]  

  • 8. APhA drug treatment protocols support clinical decision-making and patient care.
    Manolakis PG
    J Am Pharm Assoc (Wash); 1997; NS37(5):503-6. PubMed ID: 9479399
    [No Abstract]   [Full Text] [Related]  

  • 9. ASHP guidelines: minimum standard for pharmacies in institutions.
    Am J Hosp Pharm; 1985 Feb; 42(2):372-5. PubMed ID: 3976686
    [No Abstract]   [Full Text] [Related]  

  • 10. ASHP supplemental standard and learning objectives for residency training in pharmacotherapy practice. The American College of Clinical Pharmacy. American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 1996 Jan; 53(1):59-66. PubMed ID: 8719291
    [No Abstract]   [Full Text] [Related]  

  • 11. Summary of the final report of the ASHP Quality Assurance Indicators Development Group.
    Am J Hosp Pharm; 1992 Sep; 49(9):2246-51. PubMed ID: 1524071
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical lobby seeks cuts in US health research agency.
    Appel A
    Nature; 1995 Oct; 377(6548):379. PubMed ID: 7566107
    [No Abstract]   [Full Text] [Related]  

  • 13. ASHP statement on the health-system pharmacist's role in national health care quality initiatives.
    Am J Health Syst Pharm; 2010 Apr; 67(7):578-9. PubMed ID: 20237388
    [No Abstract]   [Full Text] [Related]  

  • 14. Health agency avoids Congress's axe.
    Wadman M
    Nature; 1996 Jun; 381(6582):457. PubMed ID: 8632808
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of ASHP practice standards.
    Hicks WE
    Am J Hosp Pharm; 1993 May; 50(5):878, 880. PubMed ID: 8506860
    [No Abstract]   [Full Text] [Related]  

  • 16. Reducing malpractice. Due process.
    Mettner J
    Minn Med; 2011 Feb; 94(2):10-1. PubMed ID: 21462656
    [No Abstract]   [Full Text] [Related]  

  • 17. ASHP Guidelines on Pharmacy Services in Correctional Facilities.
    Bott QD
    Am J Health Syst Pharm; 2016 Nov; 73(21):1784-1790. PubMed ID: 27769974
    [No Abstract]   [Full Text] [Related]  

  • 18. ASHP guidelines on pharmacist-conducted patient counseling.
    Am J Hosp Pharm; 1993 Mar; 50(3):505-6. PubMed ID: 8442471
    [No Abstract]   [Full Text] [Related]  

  • 19. ASHP therapeutic position statement on the daily use of aspirin for preventing cardiovascular events.
    Saseen JJ
    Am J Health Syst Pharm; 2005 Jul; 62(13):1398-405. PubMed ID: 15972384
    [No Abstract]   [Full Text] [Related]  

  • 20. ASHP statement on the use of dietary supplements.
    Kroll DJ
    Am J Health Syst Pharm; 2004 Aug; 61(16):1707-11. PubMed ID: 15540485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.